Healthcare - Biotechnology - NASDAQ - US
$ 465.7
-3.77 %
$ 120 B
Market Cap
-246.4
P/E
Price Target
Average
7.62%
Revenue Forecast
Estimate
11.77%
EBIT
Estimate
11.46%
Net Income
Estimate
17.76%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Vertex Pharmaceuticals Incorporated
Wall Street analysts predict an average 1-year price target for VRTX of $501 , with forecasts ranging from a low of $361 to a high of $600 .
VRTX Lowest Price Target
Wall Street Target
361 USD
-22.48%
VRTX Average Price Target
Wall Street Target
501 USD
7.62%
VRTX Highest Price Target
Wall Street Target
600 USD
28.84%
REVENUE FORECAST
Revenue Forecast Chart VRTX
EBIT FORECAST
EBIT Forecast Chart VRTX
NET INCOME FORECAST
Net Income Chart VRTX